Thomas G. Markees

Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.

Thomas G. Markees, Nancy E. Phillips, Emma Gordon et al. · Journal of Clinical Investigation · 1998 · 282 citations · Full text

Cell Therapy, Donor Splenocytes, T-regulatory Cell +16

Treatment of Allograft Recipients with Donor-Specific Transfusion and Anti-CD154 Antibody Leads to Deletion of Alloreactive CD8+ T Cells and Prolonged Graft Survival in a CTLA4-Dependent Manner

Neal N. Iwakoshi, John P. Mordes, Thomas G. Markees et al. · The Journal of Immunology · 2000 · 205 citations · Full text

CTLA4 Signals Are Required to Optimally Induce Allograft Tolerance with Combined Donor-Specific Transfusion and Anti-CD154 Monoclonal Antibody Treatment

Xin Xiao Zheng, Thomas G. Markees, Wayne W. Hancock et al. · The Journal of Immunology · 1999 · 175 citations · Full text

PROLONGED SURVIVAL OF MOUSE SKIN ALLOGRAFTS IN RECIPIENTS TREATED WITH DONOR SPLENOCYTES AND ANTIBODY TO CD40 LIGAND1

Thomas G. Markees, Nancy E. Phillips, Randolph J. Noelle et al. · Transplantation · 1997 · 165 citations

Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice

Edward Seung, Neal N. Iwakoshi, Bruce A. Woda et al. · Blood · 2000 · 160 citations